Postprandial hypertriglyceridaemia, defined as an increase in plasma triglyceride-containing lipoproteins following a fat meal, is a potential risk predictor of atherosclerotic cardiovascular disease and other chronic diseases. Several non-modifiable factors (genetics, age, sex and menopausal status) and lifestyle factors (diet, physical activity, smoking status, obesity, alcohol and medication use) may influence postprandial hypertriglyceridaemia. This narrative review considers the studies published over the last decade that evaluated postprandial hypertriglyceridaemia. Additionally, the genetic determinants of postprandial plasma triglyceride levels, the types of meals for studying postprandial triglyceride response, and underlying conditions (e.g. familial dyslipidaemias, diabetes mellitus, metabolic syndrome, non-alcoholic fatty liver and chronic kidney disease) that are associated with postprandial hypertriglyceridaemia are reviewed; therapeutic aspects are also considered.
Keywords: PCSK9 inhibitors; Postprandial hypertriglyceridaemia; anti-obesity drugs; atherosclerotic cardiovascular disease; bariatric surgery; chronic kidney disease; diabetes mellitus; ezetimibe; familial dyslipidaemia; fibrates; lipoprotein apheresis; metabolic syndrome; n-3 fatty acids; nicotinic acid; non-alcoholic fatty liver; oral fat tolerance test; statins; triglycerides..
Copyright© Bentham Science Publishers; For any queries, please email at [email protected].